
A Republican-backed “Right to Try” bill would allow patients to sidestep F.D.A. approval. But the true gatekeepers are the drug companies themselves. KATIE THOMAS https://ift.tt/2DQDykN https://ift.tt/2pA3pJr The New York Times Health Drugs (Pharmaceuticals), Law and Legislation March 23, 2018 at 12:00AM
Comments
Post a Comment